Advances in nanotechnology-enabled drug delivery for combining PARP inhibitors and immunotherapy in advanced ovarian cancer
Article in Biomolecules and Biomedicine (March 2024)
The most recent citing publications are shown below. View all 26 publications that cite this research output on Dimensions.
Patient-derived functional immuno-oncology platform identifies responders to ATR inhibitor and immunotherapy combinations in ovarian cancer
Preprint in bioRxiv (February 2024)
Efficacy of pembrolizumab in advanced cancer of the vulva: a systematic review and single-arm meta-analysis
Article in Frontiers in Oncology (February 2024)